INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2012
|
Total net assets |
£127.0m |
|
NAV per share |
229.0p |
|
Share price |
200.0p |
|
Total value of unquoted investments |
£20.2m |
|
Total number of portfolio companies |
66 |
|
Cash |
1% NAV |
|
Cash committed and reserved to unquoted investments |
(5)% NAV |
|
Portfolio companies with < 1 year of cash |
16.96% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Celgene Gilead |
7.6 7.3 4.5 |
|
Aptiv |
4.4 |
|
Onyx |
3.8 |
|
Alexion |
3.6 |
|
Pharmaxis |
3.3 |
|
Biogen |
3.2 |
|
YM Biosciences Insulet |
3.1 2.8 |
|
|
----------- |
|
Total |
43.6 |
|
Geographical Allocation |
% |
|
United States & Canada |
86 |
|
Europe |
10 |
|
Australia |
3 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
83 |
|
Unquoted |
16 |
|
Cash |
1 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 JANUARY 2013